A/Prof John Amerena

Experts / A/Prof John Amerena

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

By A/Prof John Amerena

Monographs

Cardiology

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

More from this expert

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.

A/Prof John Amerena

Cardiologist; Appoints at Medical School, Deakin University

More from this expert

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

SGLT2 Inhibitors – No Longer Just for Those with Diabetes

SGLT2 inhibitors are rapidly becoming seen as cardiac drugs in their own right, above and beyond their role in diabetes.

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.